John Fucci
Bios Capital Management, Lp
Assets Managed
$52.866M
Holdings
6
Last Quarter
2026 - Q1
Filed Date
1mo 19d ago
Growth Rate
-36.01%(2Q avg: -21.54%)
Sustained Growth
0 quarters
Portfolio positions
This chart displays the top 10 holdings in Bios Capital Management, Lp's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 6 positions.
Assets under management
The assets under management (AUM) of Bios Capital Management, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 52.866M in assets, with a quarterly growth rate of -36.01% and a 2-quarter average growth rate of -21.54%. The portfolio is managed by John Fucci, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
ACTU Actuate Therapeutics Inc
| 52.09% | $27.537M 10.05M shares@ $2.74 avg price | |
IRD Opus Genetics Inc
| 31.71% | $16.76M 3.683M shares@ $4.56 avg price | |
CGTX Cognition Therapeutics Inc
| 8.63% | $4.56M 6M shares@ $0.76 avg price | |
ALRN Aileron Therapeutics Inc
| 4.88% | $2.577M 1.982M shares@ $1.31 avg price | Increased 17.25% |
LTRN Lantern Pharma Inc
| 2.25% | $1.184M 864,435 shares@ $1.38 avg price | Decreased -14.37% |
INAB In8bio Inc
| 0.47% | $248,351 167,805 shares@ $1.48 avg price | Decreased -33.78% |
1-6 of 6